Enabling universal access to gene therapy through disruption of manufacturing
Viral vector-based gene therapies are the frontier of modern medicine and hold the promise to cure many genetic illnesses through single-dose treatments.
Manufacturing these complex products is highly challenging and is considered a major bottleneck of bringing these life-saving therapies to patients.
Solving this manufacturing challenge is our sole focus.
Fuse Vectors is developing a novel, infinitely scalable, cell-free gene therapy manufacturing platform. Using this platform technology, Fuse Vectors aims to develop gene therapy manufacturing processes at lighting speed; reduce cost-per-dose by orders of magnitude; and produce safe gene therapies of the highest quality.
Our team is driven by a vision to catalyze the gene therapy market through lowering barriers of entry into manufacturing for all gene therapy developers. In doing so Fuse Vectors seeks to unlock access to gene therapies for everyone - targeting global genetic disorders and ultra-rare diseases.